Introduction
Urine drug testing is a cornerstone of modern healthcare, workplace safety, and addiction recovery programs. But not all urine drug tests are the same — not even close. There is a fundamental difference between an initial drug screen and a confirmation test, and misunderstanding that difference can lead to real consequences: false positives that damage reputations, or false negatives that miss active drug use.
If you are a physician, clinic manager, employer, or anyone involved in ordering or interpreting drug tests, understanding how urine drug testing actually works — specifically the science behind immunoassay screening and LC-MS confirmation — helps you make better decisions and advocate for your patients or program more effectively.
The Two-Stage Process of Urine Drug Testing

Most urine drug testing programs follow a two-stage process:
Stage 1 — Immunoassay Screening: A fast, inexpensive test that flags samples likely to contain drugs or their metabolites.
Stage 2 — LC-MS Confirmation: A slower, more precise test that definitively identifies and quantifies specific substances in any sample that screens positive.
Both stages serve a purpose. The immunoassay gets you a quick answer. The LC-MS tells you what is actually true. Using only one without the other leaves gaps in accuracy and defensibility.
What Is Immunoassay Screening?
Immunoassay is an antibody-based technique. The test uses antibodies designed to bind to specific drug compounds or their metabolites. When those compounds are present in the urine sample, they bind to the antibodies and trigger a detectable reaction — typically a color change on a test strip or a signal in an automated analyzer.
This is the same basic technology used in many at-home pregnancy tests. It is fast, inexpensive, and relatively simple to run. An immunoassay screen can process a large volume of samples and return results in minutes.
However, immunoassay has a significant limitation: the antibodies that detect drug compounds are not perfectly selective. They can bind to structurally similar compounds that are not drugs at all. This creates false positives.
Classic examples include: certain cold medications triggering a positive result for amphetamines; poppy seeds triggering an opiate screen; some antibiotics cross-reacting with benzodiazepine tests. In a clinical setting, this means a patient could screen positive for a drug they never took — and without confirmation testing, that result could follow them in their records.
What Is LC-MS Confirmation Testing?
LC-MS stands for liquid chromatography-mass spectrometry. It is the gold standard for drug test confirmation and is used in high-complexity, accredited labs like PillarsDx.
Here is how it works: Liquid chromatography separates the different compounds present in the urine sample based on their chemical properties. Each compound travels through the chromatography column at a slightly different speed, arriving at the detector at different times (called retention time). The mass spectrometry component then measures the mass-to-charge ratio of the separated compounds, producing a unique chemical fingerprint for each substance.
The result is an analysis that can identify a specific drug or metabolite with exceptional precision — not just that ‘something like an opiate is present,’ but that this specific compound, at this specific concentration, is present in this sample.
It is nearly impossible to produce a false positive on a properly conducted LC-MS test because the test does not rely on antibody binding at all — it identifies substances by their molecular structure and weight.
Why Both Tests Are Necessary?

Running immunoassay on every sample and LC-MS only on positives is not just common practice — it is the clinically and legally defensible approach.
Immunoassay alone is insufficient because of false positives. If a result is going to be used to make a clinical decision, adjust a treatment plan, flag an employee, or report a compliance issue, it needs to be confirmed by LC-MS.
LC-MS alone on every sample would be prohibitively expensive and slow. Using immunoassay as a first-pass filter makes the overall process efficient.
At PillarsDx, our toxicology workflow incorporates both stages with 24–48 hour turnaround times, concierge pickup, and results you can act on immediately.
How This Matters for Pain Management and Addiction Recovery?
For pain management clinics, the accuracy of drug testing directly affects patient care. Monitoring whether a patient is taking prescribed medications correctly — and not using substances outside their treatment plan — requires results you can trust.
A false positive for an illicit substance could result in a patient being wrongly discharged from a pain management program. A false negative could mean missing active substance use that needs to be addressed clinically.
Similarly, in addiction recovery settings, urine drug testing is a clinical tool for tracking progress and adjusting treatment. Accuracy matters enormously for the therapeutic relationship between provider and patient.
Our team at PillarsDx understands these stakes. Our toxicology testing services are built for high-sensitivity and high-specificity, designed for the demands of behavioral health, addiction recovery, and primary care.
Synthetic Urine and Testing Integrity
One challenge that has grown significantly in recent years is the use of synthetic urine to defeat drug tests. Modern laboratory protocols can detect synthetic urine through validity testing — checking pH, creatinine levels, specific gravity, and the presence of adulterants.
PillarsDx offers specialized synthetic urine detection testing as part of our advanced testing services, giving providers and employers an added layer of confidence in the integrity of their results.
What to Look for in a Toxicology Lab Partner?
When choosing a lab for urine drug testing, accreditation matters above all else. Look for a lab that holds CLIA certification and, ideally, CAP accreditation — the two most rigorous standards in clinical laboratory medicine.
Beyond credentials, turnaround time, logistical support, and account management quality all affect how useful a lab partner actually is in practice. A result that takes five days and requires a phone call to decode is a different experience than a result that arrives in 24 hours with a clear, actionable report.
If you are evaluating lab partners for your clinic or practice in Georgia, we invite you to contact PillarsDx and see what concierge-level diagnostic service actually looks like.










